Balyasny Asset Management L.P. Sells 74,401 Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX)

Balyasny Asset Management L.P. reduced its stake in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX) by 79.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,294 shares of the company’s stock after selling 74,401 shares during the quarter. Balyasny Asset Management L.P.’s holdings in Nano-X Imaging were worth $139,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of NNOX. Northern Trust Corp boosted its holdings in Nano-X Imaging by 71.3% during the 4th quarter. Northern Trust Corp now owns 621,365 shares of the company’s stock valued at $4,474,000 after acquiring an additional 258,580 shares during the period. Susquehanna Fundamental Investments LLC bought a new stake in Nano-X Imaging in the fourth quarter valued at approximately $459,000. Headlands Technologies LLC purchased a new stake in shares of Nano-X Imaging during the fourth quarter valued at approximately $389,000. ARK Investment Management LLC boosted its stake in shares of Nano-X Imaging by 19.0% during the fourth quarter. ARK Investment Management LLC now owns 300,757 shares of the company’s stock valued at $2,165,000 after purchasing an additional 48,124 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of Nano-X Imaging in the fourth quarter worth approximately $251,000. 21.49% of the stock is owned by institutional investors.

Nano-X Imaging Stock Up 2.8%

Shares of NNOX stock opened at $5.60 on Monday. The firm has a market capitalization of $323.56 million, a price-to-earnings ratio of -6.59 and a beta of 2.03. The stock has a fifty day moving average of $5.14 and a 200 day moving average of $6.36. Nano-X Imaging Ltd. has a 52 week low of $3.75 and a 52 week high of $11.00.

Nano-X Imaging (NASDAQ:NNOX) last posted its earnings results on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. The company had revenue of $3.00 million during the quarter, compared to analysts’ expectations of $3.80 million. Equities research analysts anticipate that Nano-X Imaging Ltd. will post -0.92 earnings per share for the current year.

Wall Street Analyst Weigh In

NNOX has been the subject of a number of recent analyst reports. Cantor Fitzgerald lowered their price target on shares of Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a report on Tuesday, April 1st. D. Boral Capital reaffirmed a “buy” rating and set a $15.00 price objective on shares of Nano-X Imaging in a research note on Thursday, April 17th.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.